‘Cannot cut corners’: WHO says awaiting additional information on Covaxin

NEW DELHI: The World Health Organization on Monday said it cannot cut corners to recommend Covaxin’s inclusion in the Emergency Use Listing (EUL) for vaccination against coronavirus disease. The UN health agency said it is expecting one additional piece of information from Covaxin manufacturer, Bharat Biotech, which has been submitting data to the WHO on a rolling basis.

Covaxin EUL by the WHO is particularly significant for those planning international travel as it will also pave the way for recognition by many countries.

“We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the Covid-19 Emergency Use Listing, but we cannot cut corners- before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective,” the WHO said in a series of tweets.

“The timeframe for the WHO Emergency Use Listing procedure is dependent on how quickly a company producing the vaccine is able to provide the data required for WHO to evaluate the vaccine’s quality safety, efficacy and its suitability for low- and middle-income countries,” the WHO posted on Twitter.

The agency said that when the information provided addresses all questions raised, the WHO and the technical advisory group will complete the assessment and come to a final recommendation on whether to grant EUL to the vaccine.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s